Cancer Immunotherapy

Monitoring of Antitumor Immune Responses Necessary

Published in Cancer Weekly, May 24th, 1999

Monitoring antitumor immune responses during immunotherapy for cancer will provide insights for further improvement.

Cancer remains one of the most important public health concerns, noted researchers P. Dematos and colleagues from Duke University, North Carolina ("Monitoring Antitumor Immune Response During Immunotherapy of Cancer - Why and How'," Biodrugs, April 1999;11(4):239-247).

"Despite recent therapeutic developments, conventional therapies have provided only limited success in the management of patients with advanced disease," wrote Dematos et al. "The recent discovery of tumor-associated antigens has led to a strong interest in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1999-05-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry